Teva Hong Kong has announced a strategic partnership with Kerry Pharma, the subsidiary of Kerry Logistics Network (KLN). Leveraging Kerry Pharma's extensive logistics (fourth-party logistics, 4PL) distribution capabilities, this collaboration aims to enhance Teva's pharmaceutical distribution system in Hong Kong, Macau, and the Greater Bay Area, ensuring a stable supply of high-quality medical products.
This initiative not only strengthens Teva's presence in Hong Kong, Macau, and the Greater Bay Area, enhancing product distribution system resilience and driving quality and efficiency improvements in the regional pharmaceutical industry, but also marks a crucial step in building an efficient, transparent, and sustainable pharmaceutical supply model that prioritises patient care.
Under this collaboration, Kerry Pharma will serve as Teva's exclusive service provider in Hong Kong and Macau, leveraging its 4PL fulfilment solutions to establish a distribution network covering over 3,000 delivery points, including hospital pharmacies, clinics, drug stores and key chain channels. Through end-to-end pharmaceutical logistics solutions, the partnership will optimise inbound logistics, warehousing, distribution, billing, reporting and exports, ensuring operational efficiency and swift market responsiveness.
By leveraging digital technologies, Teva and Kerry Pharma will enhance market demand trend forecasting and optimise resource allocation capabilities, establishing a more precise pharmaceutical distribution management system, accelerating the commercialisation of Teva's innovative medicines in the Greater Bay Area and other regions across China.
